LIFTNCT07925619
Efficacy and Safety Study of L608 in Patients With Systemic Sclerosis-associated Digital Ulcers
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Time to healing of the cardinal DU
Timeframe: up to 12 weeks
Arms and interventions
L608Experimental
PlaceboPlacebo comparator
Drugs: L608, Placebo